BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15862939)

  • 1. Potential future therapies for irritable bowel syndrome: will disease modifying therapy as opposed to symptomatic control become a reality?
    Spiller RC
    Gastroenterol Clin North Am; 2005 Jun; 34(2):337-54. PubMed ID: 15862939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
    Camilleri M
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuances in treating irritable bowel syndrome.
    Frissora CL
    Rev Gastroenterol Disord; 2007; 7(2):89-96. PubMed ID: 17597676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of probiotics in IBS.
    Quigley EM
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S85-90. PubMed ID: 18542036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of probiotics in the treatment of irritable bowel syndrome.
    Wilhelm SM; Brubaker CM; Varcak EA; Kale-Pradhan PB
    Pharmacotherapy; 2008 Apr; 28(4):496-505. PubMed ID: 18363533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy options in irritable bowel syndrome.
    Enck P; Junne F; Klosterhalfen S; Zipfel S; Martens U
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1402-11. PubMed ID: 21389791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R
    Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological influences on the irritable bowel syndrome.
    Lea R; Whorwell PJ
    Minerva Med; 2004 Oct; 95(5):443-50. PubMed ID: 15467519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.
    Quigley EM
    J Dig Dis; 2007 Feb; 8(1):2-7. PubMed ID: 17261128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable bowel syndrome - The role of complementary medicines in treatment.
    Pirotta M
    Aust Fam Physician; 2009 Dec; 38(12):966-8. PubMed ID: 20369148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritable bowel syndrome: new and emerging therapies.
    Harris LA; Chang L
    Curr Opin Gastroenterol; 2006 Mar; 22(2):128-35. PubMed ID: 16462168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and therapy of irritable bowel syndrome.
    De Giorgio R; Barbara G; Stanghellini V; Cremon C; Salvioli B; De Ponti F; Corinaldesi R
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():10-22. PubMed ID: 15335409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues.
    Cuomo R; Savarese MF; Gargano R
    Dig Dis; 2007; 25(3):241-4. PubMed ID: 17827948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review.
    Heizer WD; Southern S; McGovern S
    J Am Diet Assoc; 2009 Jul; 109(7):1204-14. PubMed ID: 19559137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
    Brenner DM; Chey WD
    Rev Gastroenterol Disord; 2009; 9(1):7-15. PubMed ID: 19367213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
    Quigley EM; Flourie B
    Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome.
    van der Veek PP; van Rood YR; Masclee AA
    Aliment Pharmacol Ther; 2007 Sep; 26(6):943-52. PubMed ID: 17767479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of irritable bowel syndrome: A clinical review.
    Gilkin RJ
    Clin Ther; 2005 Nov; 27(11):1696-709. PubMed ID: 16368443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.